Article
4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN.
EMBO molecular medicine - 1 Dec 2019
Jeong Suh Young, Hogarth Penelope, Placzek Andrew, Gregory Allison M, Fox Rachel, Zhen Dolly, Hamada Jeffrey, van der Zwaag Marianne, Lambrechts Roald, Jin Haihong, Nilsen Aaron, Cobb Jared, Pham Thao, Gray Nora, Ralle Martina, Duffy Megan, Schwanemann Leila, Rai Puneet, Freed Alison, Wakeman Katrina, Woltjer Randall L, Sibon Ody Cm, Hayflick Susan J
Abstract excerpt
Pantothenate kinase-associated neurodegeneration (PKAN) is an inborn error of CoA metabolism causing dystonia, parkinsonism, and brain iron accumulation. Lack of a good mammalian model has impeded studies of pathogenesis and development of rational therapeutics. We took a new approach to investigating an existing mouse mutant of Pank2 and found that isolating the disease-vulnerable brain revealed regional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
